Skip to main content
. 2015 Jun 15;10(6):e0128540. doi: 10.1371/journal.pone.0128540

Table 2. Univariate analysis for overall survival in the development set.

Characteristics HR 95% CI P value
Age at diagnosis (median, range)
 < 65 1.000
 ≥ 65 1.597 1.258–2.028 < 0.001
Gender
 Male 1.000
 Female 1.171 0.909–1.510 0.222
Tumor size (median, range)
 ≤ 4.5 cm 1.000
 > 4.5 cm 2.725 2.119–3.505 < 0.001
Tumor location
 Lower 1/3 1.000
 Middle 1/3 1.236 0.876–1.745 0.228
 Upper 1/3 1.730 1.046–2.861 0.033
 2/3 or more 2.070 1.568–2.733 < 0.001
Lauren type
 Intestinal 1.000
 Diffuse 1.657 1.262–2.176 < 0.001
 Mixed 1.706 1.228–2.370 0.001
Depth of invasion
 T1 1.000
 T2 6.344 2.402–16.753 < 0.001
 T3 13.316 5.274–33.619 < 0.001
 T4 21.167 8.715–51.409 < 0.001
Metastatic LNs, No.
 0 1.000
 1–2 3.050 1.942–4.789 < 0.001
 3–6 4.140 2.685–6.385 < 0.001
 7–15 7.955 5.300–11.939 < 0.001
 >15 10.688 7.030–16.248 < 0.001
Histology grade
 G1-G2 1.000
 G3-G4 1.361 1.024–1.809 0.033
Lymphovascular invasion
 Negative 1.000
 Positive 2.549 2.014–3.227 < 0.001
WBC count (×103 mm-3)
 ≤ 9.5 1.000
 > 9.5 1.440 0.991–2.093 0.056
Neutrophil count (×103 mm-3)
 ≤ 6.3 1.000
 > 6.3 1.438 0.999–2.069 0.050
Lymophocyte count (×103 mm-3)
 < 1.1 1.000
 ≥ 1.1 0.611 0.441–0.846 0.003
Platelet count (×103 mm-4)
 ≤ 350 1.000
 > 350 1.222 0.797–1.873 0.357
NLR
 ≤ 50th percentile 1.000
 > 50th percentile 1.648 1.296–2.095 < 0.001
PLR
 ≤ 75th percentile 1.000
 > 75th percentile 1.762 1.372–2.264 < 0.001
Hemoglobin (g/l)
 < 115 1.000
 ≥ 115 0.713 0.557–0.913 0.007
Serum albumin (g/l)
 < 40 1.000
 ≥ 40 0.674 0.533–0.853 0.001
Plasma fibrinogen (mg/dl)
 ≤ 400 1.000
 > 400 1.724 1.351–2.200 < 0.001

Abbreviations: LNs, lymph nodes; G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated; G4, undifferentiated; WBC, white blood cells; NLR, neutrophil—lymphocyte ratio; PLR, platelet—lymphocyte ratio; HR, hazard ratio; CI, confidence interval.